Across TCGA pan-cancer cohorts, ZNF804A RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated ZNF804A data layer compared with 9 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ZNF804A RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF804A expression acts as an unfavorable survival marker, although some lineages such as HNSC and LGG show a favorable association.
HNSC, MESO, and LGG are the cancer types where ZNF804A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.